1) TSGF
恶性肿瘤特异生长因子
1.
Objective To investigate the clinical significance of URC(Urine-test Rergent for cancer screening and monitoring) and TSGF (Tumor specific Growth Factor) for the diagnosis of cancer.
目的探讨癌症尿液筛查试剂与恶性肿瘤特异生长因子单检和联合检测癌症的临床应用。
2.
Objective In order to discuss the value of combined detection of CA125 TSGF FER in the early diagnosis of ovarian cancer.
[目的 ]探讨糖蛋白抗原 12 5 (CA12 5 )、恶性肿瘤特异生长因子 (TSGF)、铁蛋白 (FER) 3种标记物联合测定在卵巢癌早期诊断、疗效监测中的临床意义。
2) TSGF
恶性肿瘤特异性生长因子
1.
Clinical application of investigate the serum of TSGF by the technique of biochemical analysis shows the color;
生化分析显色法检测血清恶性肿瘤特异性生长因子的临床应用
2.
Objective: To prove the practical value of tumor specific growth factor (TSGF) determination in malignant tumor screening and diagnosis.
目的 探讨恶性肿瘤特异性生长因子 (TSGF)检测在恶性肿瘤筛查与临床诊断中的应用价值。
3) tumor specific growth factor
恶性肿瘤特异性生长因子
1.
Objective Investigate the relationship between serum and pleural fluid CEA (carcinoembryonic antigen), CYFRA21-1 (cytokeratin 19 fragment), TSGF (tumor specific growth factor) in the diagnosis of malignant pleural applications.
目的通过对血清及胸水中CEA(癌胚抗原)、CYFRA21-1(细胞角蛋白19片段)、TSGF(恶性肿瘤特异性生长因子)的检测,探讨此三项指标在恶性胸水诊断中的应用。
4) tumor speicfic growth factor(TSGF)
恶性肿瘤特异生长因子(TSGF)
5) TSGF
肿瘤特异性生长因子
1.
The clinical value in combined detection of CA72-4,CA19-9,TSGF level in diagnosis of gastric cancer
血清糖类抗原与肿瘤特异性生长因子联合检测在胃癌临床诊断中的应用
2.
Evaluation of Detecting TSGF Levels by Immunoturbidimetric Method
免疫透射比浊法测定肿瘤特异性生长因子方法学评价
3.
Objective To study the serum values of tumor specific growth factor(TSGF),carcinoembryonic antigen(CEA),CA199 and the clinical significance in the diagnosis and prognosis in patients with colorectal carcinoma.
目的:研究大肠癌患者肿瘤特异性生长因子(TSGF)、癌胚抗原(CEA)及CA199的血清水平及其在诊断预后等方面的临床意义。
6) Tumor specific growth factor
肿瘤特异性生长因子
1.
Predictive value of tumor specific growth factor to curative effect of neoadjuvant chemotherapy for local advanced breast cancer;
血清恶性肿瘤特异性生长因子检测对乳腺癌新辅助化疗疗效的预测价值
2.
The bioluminescence immunoassay technique was combined with the colorimetric method to detect the tumor marker α-fetoprotein(AFP) and tumor specific growth factor(TSGF) of the patients sera of primary hepatocellular carcinoma(53 patients), hepatitis (80 patients) and hepatocirrhosis (34 patients).
用生物发光免疫分析法、比色法联合检测确诊的原发性肝细胞癌(53例)、乙型病毒性肝炎(80例)、慢性乙肝合并肝硬化(34例)患者同份血清的肿瘤标志物甲种胎儿蛋白(AFP)和肿瘤特异性生长因子(TSGF)。
3.
BACKGROUND&AIM: To evaluate the changes of the serum TSGF(tumor specific growth factor)in patients with breast carcinoma(BC)and their familial members(FM).
背景与目的 :评估乳腺癌患者(BC)及其家族成员(FM)血清肿瘤特异性生长因子(TSGF)水平的变化。
补充资料:恶性肿瘤的转移
恶性肿瘤的转移
transfer of malignant tumor
恶性肿瘤的转移方式有直接蔓延、淋巴道转移、血道转移及腔内种植性转移四大类。一般而言,癌常出现淋巴道转移,肉瘤则血道转移多见。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条